SCHEMBL3713372

SCHEMBL3713372

Cc1nc(-c2cc([N+](=O)[O-])c3[nH]c(-c4ccccc4)cc3c2)sc1C(=O)O

nearest known ligand 0.67

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
XDH P47989 3/20 0.67
SMN1; SMN2 Q16637 7/20 0.54
RAB9A P51151 5/20 0.53
KDM4E B2RXH2 3/20 0.47
GAA P10253 2/20 0.47
ALDH1A1 P00352 6/20 0.45
FBP1 P09467 1/20 0.43
NPC1 O15118 3/20 0.43
HPGD P15428 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
POLB P06746 1/20 0.43
KMT2A Q03164 4/20 0.42
MAPT P10636 3/20 0.42
LMNA P02545 2/20 0.42
ATM Q13315 1/20 0.42
MEN1 O00255 2/20 0.41
THRA P10827 1/20 0.40
THRB P10828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3714233 0.89 XDH (0.54) XDHSMN1; SMN2RAB9AKDM4EALDH1A1
SCHEMBL3715111 0.83 XDH (0.72) XDHSMN1; SMN2RAB9AKDM4EGAA
SCHEMBL3706018 0.81 RAB9A (0.57) XDHSMN1; SMN2RAB9AKDM4EGAA
SCHEMBL3704893 0.80 XDH (1.00) XDHSMN1; SMN2RAB9AKDM4EGAA
SCHEMBL3009122 0.75 APEX1 (0.50) XDHFBP1KMT2ALMNAMEN1
SCHEMBL3010855 0.75 CYP19A1 (0.49) XDHSMN1; SMN2RAB9AALDH1A1FBP1
SCHEMBL17629243 0.74 RAB9A (0.67) XDHSMN1; SMN2RAB9AKDM4EGAA
SCHEMBL17629244 0.74 RAB9A (0.67) XDHSMN1; SMN2RAB9AKDM4EGAA
SCHEMBL1987395 0.74 XDH (0.66) XDHSMN1; SMN2RAB9AKDM4EGAA
SCHEMBL8866822 0.73 RAB9A (0.72) SMN1; SMN2RAB9AKDM4EGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010093191-A2 NOVEL COMPOUNDS EFFECTIVE AS XANTHINE OXIDASE INHIBITORS, METHOD FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME LG LIFE SCIENCES LTD. (KR) 2010-08-19 WO claimed
WO-2010093191-A2 NOVEL COMPOUNDS EFFECTIVE AS XANTHINE OXIDASE INHIBITORS, METHOD FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME LG LIFE SCIENCES LTD. (KR) 2010-08-19 WO disclosed
WO-2010093191-A2 NOVEL COMPOUNDS EFFECTIVE AS XANTHINE OXIDASE INHIBITORS, METHOD FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME LG LIFE SCIENCES LTD. (KR) 2010-08-19 WO disclosed